Screener
Charles River Laboratories CRL RMS — Foreign exchange
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | RMS | DSA (1) | Manufacturing (2) | Total |
|---|---|---|---|---|
| December 27, 2025 | $510,844 | $1,678,518 | $574,891 | $2,764,253 |
| Acquisitions | — | 335,906 | 39,786 | 375,692 |
| Divestitures | — | (37,701) | — | (37,701) |
| Foreign exchange | (551) | (19,320) | (5,522) | (25,393) |
| June 27, 2026 | $510,293 | $1,957,403 | $609,155 | $3,076,851 |
| (1) DSA includes accumulated impairment losses of $1 billion, which were recognized in fiscal years 2008 and 2010. | ||||
| (2) Manufacturing includes accumulated impairment losses of $380 million, which were recognized in fiscal years 2024 and 2025. |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's RMS — foreign exchange?
- Charles River Laboratories (CRL) reported RMS — foreign exchange of -$808K in Q2 2026.
- How has Charles River Laboratories's RMS — foreign exchange changed year-over-year?
- Charles River Laboratories's RMS — foreign exchange decreased by 207.0% year-over-year, from $755K to -$808K.
- What does RMS — foreign exchange mean?
- This metric quantifies the impact of currency fluctuations on the financial results of the Research Models and Services segment. It captures gains or losses arising from transactions denominated in currencies other than the functional currency of the segment's operations.
Ask your AI about Charles River Laboratories's rms — foreign exchange.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude